Multiple cranial neuropathy and intracranial hypertension associated with all-trans retinoic acid treatment in a young adult patient with acute promyelocytic leukemia Labrador J; Puig N; Ortín A; Gutierrez NC; González-Díaz M. International Journal Of Hematology , 96: 383-385. FI: 1,268 (Q4) (D9) Multiple myeloma: treatment evolution San Miguel JF; Mateos MV; Ocio E; Garcia-Sanz R. Hematology , 17: 3-6. FI: 1,487 (Q3) (D8) Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide? Matarraz S; Paiva B; Diez-Campelo M; Corral LL; Pérez E; Mateos MV; Giraldo P; Hernández MT; San Miguel JF; Orfao A. Haematologica-The Hematology Journal , 97: 1608-1611. FI: 6,424 (Q1) (D1) Optimisation of mesenchymal stromal cells karyotyping analysis: implications for clinical use Muntion, S.; Sanchez-Guijo, F. M.; Carrancio, S.; Villaron, E.; Lopez, O.; Diez-Campelo, M.; San Miguel, J. F.; del Canizo, M. C. Transfusion Medicine , 22: 122-127. FI: 1,140 (Q4) (D10) Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia. Lapusan S; Vidriales MB; Thomas X; de Botton S; Vekhoff A; Tang R; Dumontet C; Morariu-Zamfir R; Lambert JM; Ozoux ML; Poncelet P; San Miguel JF; Legrand O; DeAngelo DJ; Giles FJ; Marie JP. Investigational New Drugs , 30: 1121-1131. FI: 3,357 (Q1) (D3) Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+and MLL-germline acute lymphoblastic leukemia Chillon, M. C.; Gomez-Casares, M. T.; Lopez-Jorge, C. E.; Rodriguez-Medina, C.; Molines, A.; Sarasquete, M. E.; Alcoceba, M.; Miguel, J. D. G-S; Bueno, C.; Montes, R.; Ramos, F.; Rodriguez, J. N.; Giraldo, P.; Ramirez, M.; Garcia-Delgado, R.; Fuster, J. L.; Gonzalez-Diaz, M.; Menendez, P. Leukemia , 26: 2360-2366. FI: 9,561 (Q1) (D1) Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation Cordoba, Iris; Pegenaute, Carlota; Jose Gonzalez-Lopez, Tomas; Chillon, Carmen; Eugenia Sarasquete, Maria; Martin-Herrero, Francisco; Guerrero, Carmen; Cabrero, Monica; Garcia Sanchez, Maria Helena; Pabon, Pedro; Santiago Lozano, Francisco; Gonzalez, Marcos; Alberca, Ignacio; Ramon Gonzalez-Porras, Jose. European Journal Of Haematology. , 89: 250-255. FI: 2,614 (Q2) (D5) Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival. Santamaría C; Ramos F; Puig N; Barragán E; de Paz R; Pedro C; Insunza A; Tormo M; Del Cañizo C; Diez-Campelo M; Xicoy B; Salido E; Del Real JS; Hernández M; Chillón C; Sanz GF; García-Sanz R; San Miguel JF; González M. Annals Of Hematology. , 91: 1887-1895. FI: 2,615 (Q2) (D5) SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status López-Corral L; Sarasquete ME; Beà S; García-Sanz R; Mateos MV; Corchete LA; Sayagués JM; García EM; Bladé J; Oriol A; Hernández-García MT; Giraldo P; Hernández J; González M; Hernández-Rivas JM; San Miguel JF; Gutiérrez NC. Leukemia. , 26: 2521-2529. FI: 9,561 (Q1) (D1) The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights Cañueto, Javier; Labrador, Jorge; Roman, Concepcion; Santos-Briz, Angel; Contreras, Teresa; Carmen Gutierrrez, Norma; Garcia-Sanz, Ramon. European Journal Of Haematology. , 88: 450-454. FI: 2,614 (Q2) (D5)
|
